{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T17:10:59Z","timestamp":1790010659710,"version":"4.0.1"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T00:00:00Z","timestamp":1783987200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["IJID Regions"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.ijregi.2026.100950","type":"journal-article","created":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T15:45:20Z","timestamp":1784389520000},"page":"100950","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Prevalence and antimicrobial resistance trends of ESKAPEE pathogens in clinical isolates from Hyderabad, Pakistan: a cross-sectional study"],"prefix":"10.1016","volume":"20","author":[{"given":"Muhammad Aqif","family":"Ilyas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Sameer","family":"Hashmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijregi.2026.100950_bib0001","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0140-6736(21)02724-0","article-title":"Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis","volume":"399","author":"Collaborators","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.ijregi.2026.100950_bib0002","series-title":"Tackling Drug-Resistant Infections Globally: Final Report and Recommendations. Review on Antimicrobial Resistance. Wellcome Trust and HM Government","author":"O\u2019Neill","year":"2016"},{"key":"10.1016\/j.ijregi.2026.100950_bib0003","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/S0140-6736(24)01867-1","article-title":"Global burden of bacterial antimicrobial resistance 1990\u20132021: a systematic analysis with forecasts to 2050","volume":"404","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.ijregi.2026.100950_bib0004","doi-asserted-by":"crossref","first-page":"539","DOI":"10.3389\/fmicb.2019.00539","article-title":"Emerging strategies to combat ESKAPE pathogens in the era of antimicrobial resistance: a review","volume":"10","author":"Mulani","year":"2019","journal-title":"Front Microbiol"},{"key":"10.1016\/j.ijregi.2026.100950_bib0005","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.2174\/0929867323666160304150522","article-title":"Current advances in developing inhibitors of bacterial multidrug efflux pumps","volume":"23","author":"Mahmood","year":"2016","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.ijregi.2026.100950_bib0006","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1086\/533452","article-title":"Federal funding for the study of antimicrobial resistance in nosocomial pathogens: no ESKAPE","volume":"197","author":"Rice","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijregi.2026.100950_bib0007","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/2475067","article-title":"Mechanisms of antimicrobial resistance in ESKAPE pathogens","volume":"2016","author":"Santajit","year":"2016","journal-title":"BioMed Res Int"},{"key":"10.1016\/j.ijregi.2026.100950_bib0008","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","article-title":"Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance","volume":"18","author":"Magiorakos","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijregi.2026.100950_bib0009","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1093\/cid\/ciy378","article-title":"Difficult-to-treat resistance in Gram-negative bacteremia at 173 US hospitals: retrospective cohort analysis of prevalence, predictors, and outcome of resistance to all first-line agents","volume":"67","author":"Kadri","year":"2018","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijregi.2026.100950_bib0010","series-title":"Standards I. Collection of diagnostic venous blood specimens","year":"2017"},{"key":"10.1016\/j.ijregi.2026.100950_bib0011","series-title":"Standards I. Quality control of microbiological transport systems; approved standard\u2014second edition. CLSI document M40-A2","year":"2014"},{"key":"10.1016\/j.ijregi.2026.100950_bib0012","unstructured":"Clinical, institute LS. Performance standards for antimicrobial susceptibility testing. Wayne, PA: Clinical and Laboratory Standards Institute; 2023. https:\/\/clsi.org\/shop\/standards\/m100\/."},{"key":"10.1016\/j.ijregi.2026.100950_bib0013","unstructured":"The European committee on antimicrobial susceptibility T. Breakpoint tables for interpretation of MICs and zone diameters. version 13.0; 2023. https:\/\/www.eucast.org\/fileadmin\/src\/media\/PDFs\/EUCAST_files\/Breakpoint_tables\/v_13.0_Breakpoint_Tables.pdf [accessed 8 August 2026]."},{"key":"10.1016\/j.ijregi.2026.100950_bib0014","article-title":"Prevalence of difficult-to-treat resistance in ESKAPE pathogens in a third level hospital in Mexico","volume":"7","author":"Camacho-Ortiz","year":"2025","journal-title":"Infect Prev Pract"},{"key":"10.1016\/j.ijregi.2026.100950_bib0015","unstructured":"The European committee on antimicrobial susceptibility T. Implications of breakpoints splitting the wild type and\/or resistant populations. Basel, Switzerland: EUCAST; 2016. https:\/\/www.eucast.org\/clinical_breakpoints_and_dosing\/splitting_mic_wild_type_distributions\/ [accessed 8 August 2026]."},{"key":"10.1016\/j.ijregi.2026.100950_bib0016","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1038\/s41579-024-01054-w","article-title":"ESKAPE pathogens: antimicrobial resistance, epidemiology, clinical impact and therapeutics","volume":"22","author":"Miller","year":"2024","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.ijregi.2026.100950_bib0017","doi-asserted-by":"crossref","first-page":"4727","DOI":"10.2147\/IDR.S338627","article-title":"Pathogenic characteristics and risk factors for ESKAPE pathogens infection in burn patients","volume":"14","author":"Li","year":"2021","journal-title":"Infect Drug Resist"},{"issue":"3","key":"10.1016\/j.ijregi.2026.100950_bib0018","doi-asserted-by":"crossref","first-page":"e00181","DOI":"10.1128\/CMR.00181-19","article-title":"Antimicrobial Resistance in ESKAPE Pathogens","volume":"33","author":"De Oliveira","year":"2020","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.ijregi.2026.100950_bib0019","doi-asserted-by":"crossref","DOI":"10.1136\/bmjph-2024-001312","article-title":"Antimicrobial resistance among children in Southeast Asia: a systematic review","volume":"3","author":"Duguid","year":"2025","journal-title":"BMJ Public Health"},{"key":"10.1016\/j.ijregi.2026.100950_bib0020","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.57239\/PJLSS-2024-22.1.00173","article-title":"Unveiling ESBL-Producing E. coli: genetic Markers, antibiotic Resistance, and Virulence Factors in UTI Patients Exhibiting MDR, XDR, and PDR phenotypic bacterial isolates","volume":"22","author":"Hashem","year":"2024","journal-title":"Pak.j.life.soc.sci"},{"key":"10.1016\/j.ijregi.2026.100950_bib0021","doi-asserted-by":"crossref","first-page":"525","DOI":"10.3390\/antibiotics12030525","article-title":"Estimation, evaluation and characterization of carbapenem resistance burden from a tertiary Care Hospital","volume":"12","author":"Gondal","year":"2023","journal-title":"Pakistan. Antibiotics (Basel)"},{"key":"10.1016\/j.ijregi.2026.100950_bib0022","article-title":"Bacteriological profile and antimicrobial resistance patterns in neonatal sepsis: special reference to Klebsiella pneumoniae at a tertiary Care Hospital in Eastern India","volume":"17","author":"Sau","year":"2025","journal-title":"Cureus"},{"key":"10.1016\/j.ijregi.2026.100950_bib0023","unstructured":"Al-Zalabani A, AlThobyane OA, Alshehri AH, Alrehaili AO, Namankani MO, Aljafri OH Prevalence of Klebsiella pneumoniae antibiotic resistance in Medina, Saudi Arabia, 2014\u20132018. https:\/\/www.cureus.com\/articles\/38260-prevalence-of-klebsiella-pneumoniae-antibiotic-resistance-in-medina-saudi-arabia-2014-2018. [accessed 8 August 2026]."},{"key":"10.1016\/j.ijregi.2026.100950_bib0024","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.3390\/pathogens13121136","article-title":"Antibiotic resistance trends in carbapenem-resistant Gram-negative pathogens and eight-year surveillance of XDR bloodstream infections in a Western Greece tertiary hospital","volume":"13","author":"Lagadinou","year":"2024","journal-title":"Pathogens"},{"key":"10.1016\/j.ijregi.2026.100950_bib0025","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.2147\/IDR.S312231","article-title":"Prevalence of antibiotic resistance of ESKAPE pathogens over five years in an infectious diseases hospital from South-East of Romania","volume":"14","author":"Arbune","year":"2021","journal-title":"Infect Drug Resist"},{"key":"10.1016\/j.ijregi.2026.100950_bib0026","doi-asserted-by":"crossref","first-page":"94","DOI":"10.54393\/pjhs.v6i9.2080","article-title":"Frequency of carbapenem resistance in the pathogenic Gram-negative bacteria from Hyderabad, Sindh: carbapenem resistance in the pathogenic Gram-negative bacteria","volume":"6","author":"Ilyas","year":"2025","journal-title":"PJHS-Lahore"},{"key":"10.1016\/j.ijregi.2026.100950_bib0027","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2025.1489317","article-title":"Systematic review of multidrug-resistant Klebsiella pneumoniae in the Arabian Peninsula: molecular epidemiology and resistance patterns","volume":"16","author":"Idrees","year":"2025","journal-title":"Front Microbiol"},{"key":"10.1016\/j.ijregi.2026.100950_bib0028","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.2147\/IDR.S365139","article-title":"Trends in DTR, CR, ECR, and FQR in four common Gram-negative bacteria: a retrospective study from 2013 to 2021","volume":"15","author":"Zhang","year":"2022","journal-title":"Infect Drug Resist"},{"key":"10.1016\/j.ijregi.2026.100950_bib0029","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0321935","article-title":"Difficult-to-treat resistant Pseudomonas aeruginosa infections in Lebanese hospitals: impact on mortality and the role of initial antibiotic therapy","volume":"20","author":"Itani","year":"2025","journal-title":"PLoS One"},{"key":"10.1016\/j.ijregi.2026.100950_bib0030","first-page":"265","article-title":"Detection of multidrug resistant (MDR) and extremely drug resistant (XDR) P. aeruginosa isolated from patients in Tehran, Iran","volume":"10","author":"Saderi","year":"2015","journal-title":"Iran J Pathol"},{"key":"10.1016\/j.ijregi.2026.100950_bib0031","doi-asserted-by":"crossref","first-page":"dlaf134","DOI":"10.1093\/jacamr\/dlaf134","article-title":"The global epidemiology of carbapenem-resistant Acinetobacter baumannii","volume":"7","author":"Boutzoukas","year":"2025","journal-title":"JAC Antimicrob Resist"},{"key":"10.1016\/j.ijregi.2026.100950_bib0032","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1097\/JS9.0000000000000184","article-title":"Carbapenem-resistant Pseudomonas aeruginosa in intensive care units increase mortality as an emerging global threat","volume":"109","author":"Saravanan","year":"2023","journal-title":"Int J Surg"},{"key":"10.1016\/j.ijregi.2026.100950_bib0033","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.2147\/IDR.S306688","article-title":"Characterisation of ESKAPE pathogens with special reference to multidrug resistance and biofilm production in a Nepalese hospital","volume":"14","author":"Pandey","year":"2021","journal-title":"Infect Drug Resist"},{"key":"10.1016\/j.ijregi.2026.100950_bib0034","first-page":"15","article-title":"Multidrug resistance and extensively drug-resistance in Staphylococcus aureus, Staphylococcus epidermidis, and Staphylococcus haemolyticus","volume":"16","author":"Haliman","year":"2023","journal-title":"Microbiol Indones"},{"key":"10.1016\/j.ijregi.2026.100950_bib0035","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/4065603","article-title":"Multidrug resistant and extensively drug resistant bacteria: a study","volume":"2016","author":"Basak","year":"2016","journal-title":"J Pathog"},{"key":"10.1016\/j.ijregi.2026.100950_bib0036","doi-asserted-by":"crossref","DOI":"10.1016\/j.glmedi.2024.100065","article-title":"Antibiotic dispensation without prescription by community pharmacies in Pakistan","volume":"2","author":"Nohri","year":"2024","journal-title":"J Med Surg Public Health"},{"key":"10.1016\/j.ijregi.2026.100950_bib0037","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1007\/s10903-021-01228-1","article-title":"Bringing medicine from Pakistan and self-medication among Pakistani mothers in New Zealand","volume":"24","author":"Akhtar","year":"2022","journal-title":"J Immigr Minor Health"},{"key":"10.1016\/j.ijregi.2026.100950_bib0038","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1017\/ice.2023.137","article-title":"Strategies to prevent catheter-associated urinary tract infections in acute-care hospitals: 2022 update","volume":"44","author":"Patel","year":"2023","journal-title":"Infect Control Hosp Epidemiol"}],"container-title":["IJID Regions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772707626001128?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772707626001128?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T16:43:21Z","timestamp":1790009001000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772707626001128"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":38,"alternative-id":["S2772707626001128"],"URL":"https:\/\/doi.org\/10.1016\/j.ijregi.2026.100950","relation":{},"ISSN":["2772-7076"],"issn-type":[{"value":"2772-7076","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevalence and antimicrobial resistance trends of ESKAPEE pathogens in clinical isolates from Hyderabad, Pakistan: a cross-sectional study","name":"articletitle","label":"Article Title"},{"value":"IJID Regions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijregi.2026.100950","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}],"article-number":"100950"}}